Lombardi, Carlo Mario
 Distribuzione geografica
Continente #
NA - Nord America 9.271
EU - Europa 5.082
AS - Asia 2.948
OC - Oceania 18
AF - Africa 16
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 6
Totale 17.352
Nazione #
US - Stati Uniti d'America 9.239
CN - Cina 1.424
UA - Ucraina 1.248
PL - Polonia 1.040
IT - Italia 695
DE - Germania 647
SG - Singapore 620
FI - Finlandia 392
HK - Hong Kong 368
TR - Turchia 272
RU - Federazione Russa 249
IE - Irlanda 248
GB - Regno Unito 205
IN - India 174
FR - Francia 152
SE - Svezia 81
VN - Vietnam 36
BE - Belgio 35
CZ - Repubblica Ceca 34
CA - Canada 28
NL - Olanda 23
AU - Australia 15
ID - Indonesia 11
JP - Giappone 7
TH - Thailandia 7
EU - Europa 6
MU - Mauritius 6
BR - Brasile 5
ES - Italia 5
SA - Arabia Saudita 5
TN - Tunisia 5
AL - Albania 4
HU - Ungheria 4
IR - Iran 4
PH - Filippine 4
AZ - Azerbaigian 3
CL - Cile 3
NZ - Nuova Zelanda 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
AR - Argentina 2
BG - Bulgaria 2
EE - Estonia 2
EG - Egitto 2
HR - Croazia 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
NO - Norvegia 2
PK - Pakistan 2
SI - Slovenia 2
ZA - Sudafrica 2
BD - Bangladesh 1
BY - Bielorussia 1
CH - Svizzera 1
DZ - Algeria 1
FK - Isole Falkland (Malvinas) 1
HT - Haiti 1
IQ - Iraq 1
KG - Kirghizistan 1
KR - Corea 1
LV - Lettonia 1
MD - Moldavia 1
MX - Messico 1
MY - Malesia 1
PA - Panama 1
PR - Porto Rico 1
Totale 17.352
Città #
Fairfield 1.244
Warsaw 1.039
Jacksonville 919
Woodbridge 792
Ashburn 756
Chandler 628
Houston 588
Seattle 524
Cambridge 520
Singapore 506
Wilmington 500
Ann Arbor 481
Princeton 447
Hong Kong 367
Nanjing 313
Beijing 270
Helsinki 269
Dublin 247
Istanbul 234
New York 223
Moscow 118
Pune 107
Nanchang 100
Des Moines 96
Brescia 95
Shenyang 89
Dearborn 85
Changsha 84
San Diego 83
Hebei 78
Shanghai 71
Milan 67
Tianjin 60
Jiaxing 57
Jinan 55
Munich 48
London 39
Los Angeles 38
Romola 38
Dong Ket 34
Kocaeli 34
Brussels 33
Kunming 31
Brno 30
Lancaster 29
Hangzhou 28
Rome 28
Frankfurt am Main 27
Verona 27
Ningbo 25
Zhengzhou 22
San Francisco 21
Taizhou 20
Haikou 18
Orange 17
Washington 16
Guangzhou 15
Lanzhou 15
Boardman 13
Toronto 13
Jakarta 9
Lappeenranta 9
Kilburn 8
Taiyuan 8
Canberra 7
Falkenstein 7
Norwalk 7
Padova 7
Phoenix 7
Prevalle 7
Stockholm 7
Acton 6
Espoo 6
Florence 6
Hanover 6
Novara 6
Ottawa 6
Catania 5
Chicago 5
Leipzig 5
North York 5
Peccioli 5
Riyadh 5
Strasbourg 5
Tokyo 5
Augusta 4
Bangkok 4
Bologna 4
Calcinato 4
Changchun 4
Curno 4
Fuzhou 4
Hefei 4
Naples 4
New Bedfont 4
Olomouc 4
Palermo 4
Redwood City 4
Reggio Nell'emilia 4
Rende 4
Totale 12.990
Nome #
Worsening renal function in patients hospitalised for acute heart failure: Clinical implications and prognostic significance 273
Impact of serial troponin release on outcomes in patients with acute heart failure: Analysis from the protect pilot study 246
Hemodynamic Predictors of Heart Failure Morbidity and Mortality: Fluid or Flow? 231
Can we improve the treatment of congestion in heart failure? 221
Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. 216
Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. 212
May 2020 at a glance: ischaemic heart failure and sex-related differences 212
Acute heart failure: multiple clinical profiles and mechanisms require tailored therapy. 209
Troponin T levels in patients with acute heart failure : clinical and prognostic significance of their delection and release during hospitalisation 191
Use of inotropic agents in patients with advanced heart failure: lessons from recent trials and hopes for new agents. 164
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: A long-term comparison 149
Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry 148
Percutaneous edge-to-edge mitral valve repair for the treatment of acute mitral regurgitation complicating myocardial infarction: A single centre experience 147
Fattori di rischio ed “epidemiologia inversa” nei pazienti con insufficienza cardiaca. 144
Amino acids and derivatives, a new treatment of chronic heart failure? 142
Mitraclip therapy in patients with functional mitral regurgitation and missing leaflet coaptation: is it still an exclusion criterion? 137
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 134
Effects of ivabradine on endothelial function, aortic properties and ventricular-arterial coupling in chronic systolic heart failure patients 130
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry 123
Prognostic Value of Serial Clinical, Laboratory and Ecocardiographic Tests in Ambulatory Patients with Chronic Heart Failure 120
Nutritional Supplementation with Amino Acids in Ambulatory Patients with Idiophatic Dilatated Cardiomyophaty 119
Neurohormonal activation in acute heart failure: results from VERITAS 115
N-3 PUFA increase bioavailability and function of endothelial progenitor cells 114
Clinical Presentation and Outcome in a Contemporary Cohort of Patients with Acute Myocarditis: The Multicenter Lombardy Registry 114
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 113
The management of acute heart failure. 112
Can we prevent or treat renal dysfunction in acute heart failure? 111
Cardiovascular and non cardiovascular comorbidities in patients with chronic heart failure. 108
N-terminal pro-B-type natriuretic peptide-guided therapy in patients hospitalized for acute heart failure 108
Anemia and heart failure : a cause of progression or only a consequence? 107
Prognostic value of the absolute lymphocyte count in patients admitted for acute heart failure 107
The effect of aldosterone-antagonist therapy on aortic elastic properties in patients with nonischemic dilated cardiomyopathy 106
Mineralocorticoid receptor antagonists for heart failure: a real-life observational study 106
Heart failure and anemia: Effects on prognostic variables 105
Serelaxin a novel treatment for acute heart failure 104
A systematic review of in-hospital worsening heart failure as an endpoint in clinical investigations of therapy for acute heart failure 102
Renal dysfunction in acute heart failure: epidemiology, mechanisms and assessment. 101
Echocardiographic elastic properties of ascending aorta and their relationship with exercise capacity in patients with non-ischemic dilated cardiomyopathy 101
Effects of oral amino Acid supplements on functional capacity in patients with chronic heart failure. 101
Independent role of resting heart rate at discharge as a predictor of mortality after hospitalisation for acute heart failure. 100
Nutrition and Cardiovascular Disease: Finding the Perfect Recipe for Cardiovascular Health 100
Prognostic role of atrial fibrillation in patients affected by chronic heart failure. Data from the MECKI score research group 99
Effects of oral administration of orodispersible levo-carnosine on quality of life and exercise performance in patients with chronic heart failure. 98
The need for evaluating right ventricular adaptation and ventriculo–arterial coupling 98
Six-year prognosis of diabetic patients with coronary artery disease. 97
Novel insight into the dangerous connection between diabetes and heart failure 97
Dose-dependent efficacy of β-blocker in patients with chronic heart failure and atrial fibrillation 97
Nutritional Deficiency in Patients with Heart Failure. 95
Assessment of Congestion in Acute Heart Failure: When Simplicity Does Not Go Along With Accuracy 95
Exercise performance is a prognostic indicator in elderly patients with chronic heart failure: Application of metabolic exercise cardiac kidney indexes score 94
Exercise tolerance can explain the obesity paradox in patients with systolic heart failure: data from the MECKI Score Research Group 93
Red cell distribution width and chronic heart failure: prognostic role beyond echocardiographic parameters. 93
Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertension 93
Prediction of 1-year outcomes after an acute heart failure hospitalisation: importance of variables measured at the time of discharge. 92
Relative Efficacy of Sacubitril-Valsartan, Vericiguat, and SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction: a Systematic Review and Network Meta-Analysis 92
Role of fluid retention in patients hospitalised for acute heart failure. 91
Effects of Spironolactone on Long-term Mortality and Morbidity in Patients With Heart Failure and Mild or No Symptoms. 91
Significato prognostico indipendente della frequenza cardiaca a riposo alla dimissione come predittore di mortalità in pazienti ricoverati per insufficienza cardiaca acuta. 90
Prognostic Evaluation Of The Ascending Aorta's Elastic Properties In Patients With Non-Ischemic Dilated Cardiomyopathy: An Echocardiographic Long-Term Follow-Up Study. 90
Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the PROTECT pilot study. 89
Effect of bosentan on exercise capacity and clinical worsening in patients with dual down and eisenmenger syndrome 89
Is there a role for ivabradine beyond its conventional use? 88
Apnee notturne e insufficienza cardiaca: un problema in via di soluzione. 88
Cardiorenal Interactions 88
Prognostic value of serial measurements of blood urea nitrogen in ambulatory patients with chronic heart failure 87
Irreversible proteasome inhibition with carfilzomib as first line therapy in patients with newly diagnosed multiple myeloma: early in vivo cardiovascular effects 87
Iron deficiency in heart failure 87
Updates in heart failure: what last year brought to us 87
Chronic kidney disease and worsening renal function in acute heart failure: different phenotypes with similar prognostic impact? 86
Serum potassium decline during hospitalization for acute decompensated heart failure is a predictor of 6-month mortality, independent of N-terminal pro-B-type natriuretic peptide levels: An individual patient data analysis 86
In-hospital worsening heart failure in patients admitted for acute heart failure 86
Dobutamine stress echocardiography in pulmonary arterial hypertension 86
Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure 85
Mode of death and hospitalization from the second follow-up serial infusions of nesiritide (FUSION II) trial and comparison of clinical events committee adjudicated versus investigator reported outcomes 84
Preoperative cardiac risks in noncardiac surgery: The role of coronary angiography 84
Endomyocardial fibrosis and myocardial infarction leading to diastolic and systolic dysfunction requiring transplantation 84
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy 84
Long-term prognostic value of peak VO2 in patients with heart failure on chronic beta-blocker therapy. 83
Valore prognostico delle variazioni dell'indice di distribuzione dei volumi eritrocitari (RDW) nello scompenso cardiaco cronico. 83
The Additional Role Of Diabetes Mellitus On Hypertension-Related Aortic Stiffness. 83
Early readmission for heart failure: An avoidable or ineluctable debacle? 82
Successful switch to sitaxsentan in a patient with HIV-related pulmonary arterial hypertension and late intolerance to nonselective endothelin receptor blockade 81
Arterial Stiffness And Ventricular-Arterial Coupling In Hfref. 81
January 2020 at a glance: translational medicine, predictors of outcome and treatments 81
September 2019 at a glance: focus on devices 80
Le pressioni di riempimento ventricolari e la risposta ventilatoria allo sforzo identificano i pazienti con insufficienza cardiaca ad alto rischio di eventi nonostante la terapia beta-bloccante. 79
Acute heart failure: The heart failure patient's journey-the vulnerable phase: Bibliography of one hundred key papers 79
Acute heart failure 79
De novo acute heart failure and acutely decompensated chronic heart failure: one single syndrome or two different entities? 78
Carnosine: Potential aid for diabetes and cardiovascular disease 78
Effect of bosentan on exercise capacity and clinical worsening in patients with dual Down and Eisenmenger syndrome 77
Body Mass Index Paradox In Acute Herat Failure 76
Prognostic value of blood urea nitrose and its changes in patients with chronic heart failure. 73
Reversal by the selective D2 dopamine receptor blocker sulpiride of the hypotensive effect of co-dergocrine in elderly hypertensive patients. 72
Treatment of Patients Recently Admitted for Acute Heart Failure Based on NT-proBNP Plasma Levels Measurements. Results of a Prospective, Randomized, Single-centre Trial 71
Geographic Differences in Patients in a Global Acute Heart Failure Clinical Trial (from the ASCEND-HF Trial) 70
Acute heart failure: More questions than answers 70
School and family-based interventions for promoting a healthy lifestyle among children and adolescents in Italy: A systematic review 69
La terapia con inotropi del paziente con insufficienza cardiaca: oltre i farmaci tradizionali 68
Highlights in heart failure 68
Totale 10.814
Categoria #
all - tutte 104.125
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.125


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.559 0 0 0 0 0 448 350 429 274 579 209 270
2020/20213.291 124 450 98 444 191 382 98 368 358 367 262 149
2021/20221.621 72 245 42 119 48 77 42 142 80 197 166 391
2022/20231.749 262 92 27 125 168 468 5 165 274 14 84 65
2023/20242.064 124 32 210 172 123 422 92 77 410 50 47 305
2024/20251.528 46 57 73 532 456 364 0 0 0 0 0 0
Totale 17.720